rs546352116
Variant summary
Our verdict is Likely benign. Variant got -1 ACMG points: 3P and 4B. PM2PP2BP4_Strong
The NM_001374736.1(DST):āc.4269A>Gā(p.Ile1423Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000395 in 1,594,656 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Consequence
NM_001374736.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -1 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
DST | NM_001374736.1 | c.4269A>G | p.Ile1423Met | missense_variant | 31/104 | ENST00000680361.1 | NP_001361665.1 | |
DST | NM_001723.7 | c.2658A>G | p.Ile886Met | missense_variant | 17/24 | ENST00000370765.11 | NP_001714.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DST | ENST00000680361.1 | c.4269A>G | p.Ile1423Met | missense_variant | 31/104 | NM_001374736.1 | ENSP00000505098 | |||
DST | ENST00000370765.11 | c.2658A>G | p.Ile886Met | missense_variant | 17/24 | 1 | NM_001723.7 | ENSP00000359801 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152260Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000798 AC: 20AN: 250670Hom.: 0 AF XY: 0.0000590 AC XY: 8AN XY: 135530
GnomAD4 exome AF: 0.0000326 AC: 47AN: 1442278Hom.: 0 Cov.: 27 AF XY: 0.0000292 AC XY: 21AN XY: 718700
GnomAD4 genome AF: 0.000105 AC: 16AN: 152378Hom.: 0 Cov.: 32 AF XY: 0.000107 AC XY: 8AN XY: 74512
ClinVar
Submissions by phenotype
Hereditary sensory and autonomic neuropathy type 6;C3809470:Epidermolysis bullosa simplex 3, localized or generalized intermediate, with BP230 deficiency Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 10, 2022 | This sequence change replaces isoleucine, which is neutral and non-polar, with methionine, which is neutral and non-polar, at codon 886 of the DST protein (p.Ile886Met). This variant is present in population databases (rs546352116, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with DST-related conditions. ClinVar contains an entry for this variant (Variation ID: 541466). Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Benign"; Align-GVGD: "Class C0". The methionine amino acid residue is found in multiple mammalian species, which suggests that this missense change does not adversely affect protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 27, 2020 | The p.I1390M variant (also known as c.4170A>G), located in coding exon 30 of the DST gene, results from an A to G substitution at nucleotide position 4170. The isoleucine at codon 1390 is replaced by methionine, an amino acid with highly similar properties. This amino acid position is not well conserved in available vertebrate species. In addition, this alteration is predicted to be tolerated by in silico analysis. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at